Uncommon low-grade brain tumors
- PMID: 30239861
- PMCID: PMC6374757
- DOI: 10.1093/neuonc/noy151
Uncommon low-grade brain tumors
Abstract
The 2016 World Health Organization (WHO) classification of primary central nervous system (CNS) tumors includes numerous uncommon (representing ≤1% of tumors) low-grade (grades I-II) brain neoplasms with varying clinical behaviors and outcomes. Generally, gross tumor or maximal safe resection is the primary treatment. Adjuvant treatments, though their exact role is unknown, may be considered individually based on pathological subtypes and a proper assessment of risks and benefits. Targetable mutations such as BRAF (proto-oncogene B-Raf), TRAIL (tumor necrosis factor apoptosis inducing ligand), and PDGFR (platelet derived growth factor receptor) have promising roles in future management.
Keywords: brain tumors; low-grade; mutations; treatment.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
-
- Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
-
- Kasper BS, Kasper EM. New classification of epilepsy-related neoplasms: the clinical perspective. Epilepsy Behav. 2017;67:91–97. - PubMed
-
- Zhang D, Henning TD, Zou LG, et al. . Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients. Clin Radiol. 2008;63(1):80–91. - PubMed
-
- Rades D, Zwick L, Leppert J, et al. . The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer. 2010;116(2):432–442. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
